Upload
guido
View
36
Download
0
Embed Size (px)
DESCRIPTION
Optimizing Treatment for HER2-Positive Advanced Breast Cancer. Program Goals. CLEOPATRA Study Design. First-Line Therapy of HER2+ MBC. Therapy of MBC After Progression on First-Line Anti-HER2 Treatment. EMILIA: PFS. EMILIA: OS at Second Interim Analysis. EMILIA: Hematologic Adverse Events. - PowerPoint PPT Presentation
Citation preview
Optimizing Treatment forHER2-Positive Advanced Breast
Cancer
Program Goals
CLEOPATRA Study Design
First-Line Therapy of HER2+ MBC
Therapy of MBC After Progression on First-Line Anti-
HER2 Treatment
EMILIA: PFS
EMILIA: OS at Second Interim Analysis
EMILIA: Hematologic Adverse Events
First-Line Treatment With T-DM1 vs Trastuzumab +
Docetaxel
BOLERO-3: Previous Therapy